Research Overview: Mod GRF 1-29 10mg Nouveaux
Mod GRF 1-29 is a synthetic modified growth hormone releasing hormone (GHRH) analogue designed for in-vitro laboratory research applications. This peptide compound represents an advanced research tool for scientists investigating growth hormone signalling pathways and cellular mechanisms. The Nouveaux formulation provides researchers with a high-purity peptide suitable for detailed molecular studies examining GHRH receptor interactions and downstream cellular responses. Research facilities can Stroid UK Shop to access laboratory-grade compounds for comprehensive peptide research protocols.
Laboratory Applications and Research Studies
Research teams examine Mod GRF 1-29 to study growth hormone releasing mechanisms in controlled laboratory environments. Scientists investigate how this modified GHRH analogue interacts with specific receptor sites to understand cellular signalling cascades. Laboratory protocols evaluate the peptide’s stability characteristics and molecular behaviour under various experimental conditions. Researchers analyse the compound’s structural modifications compared to native GHRH to determine functional differences in receptor binding affinity. Studies examine cellular responses to peptide exposure, measuring changes in growth factor expression and protein synthesis markers. The muscle building products peptides category contains related compounds for comparative research studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Purity | ≥98% (HPLC) |
| Peptide Sequence | Modified GHRH 1-29 |
| Vial Content | 10mg lyophilised powder |
| Storage | -20°C, protected from light |
| Stability | 2 years when stored correctly |
| Reconstitution | Bacteriostatic water recommended |
Research laboratories can explore additional peptide compounds through our comprehensive peptides collection for comparative molecular studies. Scientists requiring complementary research compounds may examine options in the SARMs category for multi-pathway research protocols.
Research Compliance Statement
Mod GRF 1-29 10mg Nouveaux is manufactured exclusively for in-vitro research purposes and laboratory analysis only. This peptide is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must comply with all applicable regulations governing peptide research and maintain proper laboratory protocols when handling this compound.
